M&T Bank Corp Nektar Therapeutics Transaction History

M&T Bank Corp

  • $29.1 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Jul 29, 2020
SELL
$16.86 - $23.44 $17,534 - $24,377
-1,040 Closed
0 $0
Q1 2020

May 14, 2020
BUY
$14.47 - $27.96 $15,048 - $29,078
1,040 New
1,040 $18.6 Million
Q4 2018

Feb 01, 2019
SELL
$30.43 - $56.65 $169,677 - $315,880
-5,576 Closed
0 $0
Q3 2018

Nov 09, 2018
BUY
$46.46 - $68.49 $259,060 - $381,900
5,576 New
5,576 $340,000

Others Institutions Holding NKTR

# of Institutions
140
Shares Held
135M
Call Options Held
32.8K
Put Options Held
55.5K
View Full List

About NEKTAR THERAPEUTICS

NKTR Quotes by TradingView
  • Ticker NKTR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 187,404,992
  • Market Cap $244M
  • Description
  • Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...
More about NKTR
Track This Portfolio

Track M&T Bank Corp Portfolio

Follow M&T Bank Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of M&T Bank Corp, based on Form 13F filings with the SEC.

News

Stay updated on M&T Bank Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email